MDT - 3 Diabetes Care Stocks That Could Help Set You Up for Life
Diabetes has been on the rise for a while because of both the aging of the U.S. population -- as well as expanding waistlines. According to the National Diabetes Statistics Report, 37.3 million people in the United States have diabetes, and 96 million in the U.S. have pre-diabetes, including 48.8% of the population that is 65 or older.
A recent report by Global Market Insights puts the compound annual growth rate for the diabetes care devices market at 10% between now and 2030, becoming an $88 billion market by that time.
DexCom (NASDAQ: DXCM) , Medtronic (NYSE: MDT) and Abbott Laboratories (NYSE: ABT) , three of the largest manufacturers of continuous glucose monitoring management systems (CGMs) for diabetes care, are healthcare companies that are well-positioned to benefit from the growing number of people with diabetes worldwide.
For further details see:
3 Diabetes Care Stocks That Could Help Set You Up for Life